Shawn Cross Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Shawn Cross is Chief Financial Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 56,250 shares of PCRX, which is worth approximately $1.34 Million. The most recent transaction as insider was on Nov 10, 2025, when has been sold 12,060 shares (Common Stock) at a price of $22.09 per share, resulting in proceeds of $266,405. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.3K
25.0% 3M change
25.0% 12M change
Total Value Held $1.34 Million

Shawn Cross Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2025
SELL
Open market or private sale
$266,405 $22.09 p/Share
12,060 Reduced 17.65%
56,250 Common Stock
Oct 31 2025
SELL
Payment of exercise price or tax liability
$143,032 $21.38 p/Share
6,690 Reduced 8.92%
68,310 Common Stock
Nov 01 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock

Also insider at

AMTI
Applied Molecular Transport Inc. Healthcare
CEO & Chair of the Board
CYTH
Cyclo Therapeutics, Inc. Healthcare
Director
SC

Shawn Cross

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX